The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels

NACompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

May 31, 2015

Conditions
Coronary Artery Disease
Interventions
DEVICE

PROMUS Element Coronary Stent System

PROMUS Element is a device/drug combination product composed of two components, a device (coronary stent system including a platinum chromium stent platform) and a drug product (a formulation of everolimus contained in a polymer coating)

Trial Locations (23)

3065

St. Vincent's Hospital, Fitzroy

3600

Ziekenhuis Oost Limburg, Genk

27401

Moses H. Cone Memorial Hospital/LeBauer Cardiovascular Research Foundation, Greensboro

27610

Wake Medical Center, Raleigh

31059

Centre Hôpital Universitaire Rangueil, Toulouse

31076

Clinique Pasteur, Toulouse

32803

Florida Hospital, Orlando

34471

Mediquest Research at Munroe Regional Medical Center, Ocala

40202

Jewish Hospital & St. Mary's Healthcare, Louisville

43124

Ohio Health Research and Innovation Institute, Columbus

45219

Lindner Center for Research and Education at The Christ Hospital, Cincinnati

49770

Northern Michigan Hospital, Petoskey

55407

Abbott Northwestern Hospital, Minneapolis

62701

St. John's Hospital, Springfield

73120

Oklahoma Foundation for Cardiovascular Research, Oklahoma City

75226

Baylor Heart & Vascular Hospital, Dallas

78229

TexSAn Heart Hospital, San Antonio

93301

Bakersfield Memorial Hospital, Bakersfield

VIC 3168

Monash Medical Centre, Clayton

B-3000

UZ Gasthuisberg, Leuven

Unknown

Shonan Kamakura General Hospital, Kamakura-shi

Sakurabashi Watanabe Hospital, Osaka

0622

North Shore Hospital, Takapuna

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY